With only a snort a week, a new drug might keep patients safe from several viruses — and the University of Maryland is willing to pay more than $1,000 for people willing to test it. The nasal spray ...
As bird flu continues to circulate in animals and spill over into humans, researchers are racing to stop it before it adapts to spread widely between people. A new nasal spray vaccine showed strong ...
An antibody nasal spray has shown promise for protecting against flu in preliminary human trials, after first being validated in mice and monkeys. It may be useful for combatting future flu pandemics ...
CLEVELAND, Ohio — Families can now test for flu, COVID-19 and respiratory syncytial virus with one at-home test. The Flowflex® Plus RSV + Flu A/B + COVID 4-in-1 test is now available in Northeast Ohio ...
Nasal vaccines offer an option to those afraid of needles, situations where mass vaccination is required, or for those seeking an at-home option, but there are restrictions on who should receive the ...
The use of LuerVax® and Spray Divider™ support Aptar’s commitment to advancing drug delivery and next-generation vaccine development, backed by comprehensive regulatory and technical expertise CRYSTAL ...
The use of LuerVax® and Spray Divider™ support Aptar’s commitment to advancing drug delivery and next-generation vaccine development, backed by comprehensive regulatory and technical expertise ...
The CDC reports that COVID-19 infections are growing or likely growing in 37 states, including Ohio. COVID-19 hospitalizations in Ohio more than doubled from early to late December, coinciding with ...
A recent nasal spray recall has expanded to another brand, with the Federal Drug Administration saying the products were found to contain mold and unsafe levels of bacteria as customers are urged to ...
A pharmaceutical company has expanded a recall on nasal spray products because of possible yeast, mold and microbial contamination, which could lead to infections. MediNatura New Mexico, Inc. issued ...
Respiratory viruses that have diverse strains and mutate rapidly, such as influenza and COVID-19, are difficult to block perfectly with vaccines alone. To solve this problem, KAIST's research team has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results